enVVeno Medical (NVNO) Notes Payables (2017 - 2021)

enVVeno Medical's Notes Payables history runs 3 years deep, the most recent figure standing at $312700.0 for Q2 2021.

• On a quarterly basis, Notes Payables rose 11.21% year-over-year to $312700.0 in Q2 2021; TTM through Jun 2021 was $312700.0, a 11.21% increase from a year earlier, with the FY2020 full-year figure at $312700.0, changed N/A from the prior year.
• Notes Payables held at $312700.0 in Q2 2021 per NVNO's latest filing, from $312700.0 in the prior quarter.
• Across five years, Notes Payables topped out at $3.1 million in Q4 2017 and bottomed at $199907.0 in Q1 2020.
• The 3-year median for Notes Payables is $312700.0 (2020), against an average of $686972.6.
• Biggest YoY gain for Notes Payables was 56.42% in 2021; the steepest drop was 11.21% in 2021.
• Year by year, Notes Payables stood at $3.1 million in 2017, then sank by 89.84% to $312700.0 in 2020, then changed by 0.0% to $312700.0 in 2021.
• Per Business Quant, the three latest NVNO Notes Payables figures stand at $312700.0 (Q2 2021), $312700.0 (Q1 2021), and $312700.0 (Q4 2020).